International Journal of Cardiology
Volume 129, Issue 2 , Pages 198-204 , 26 September 2008

Differences in management and outcome of ischemic and non-ischemic cardiomyopathy

  • Austin Chin Chwan Ng

      Affiliations

    • Concord RG Hospital, Department of Cardiology, Hospital Road, Concord 2139 NSW Australia
    • The University of Sydney, Hospital Road, Concord 2139 NSW Australia
    • Tel.: +61 2 9767 5215; fax: +61 2 9767 6994.
    • ,
  • Andrew Paul Sindone

      Affiliations

    • Concord RG Hospital, Department of Cardiology, Hospital Road, Concord 2139 NSW Australia
    • The University of Sydney, Hospital Road, Concord 2139 NSW Australia
    • Tel.: +61 2 9767 5215; fax: +61 2 9767 6994.
    • ,
  • Helen Siu Ping Wong

      Affiliations

    • Concord RG Hospital, Department of Cardiology, Hospital Road, Concord 2139 NSW Australia
    • Tel.: +61 2 9767 5215; fax: +61 2 9767 6994.
    • ,
  • Saul Benedict Freedman

      Affiliations

    • Concord RG Hospital, Department of Cardiology, Hospital Road, Concord 2139 NSW Australia
    • The University of Sydney, Hospital Road, Concord 2139 NSW Australia
    • Anzac Research Institute, Hospital Road, Concord 2139 NSW Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9767 7358; fax: +61 2 9767 6780.

Received 28 May 2007 ,Accepted 1 July 2007.

References 

  1. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402
  2. Krum H. Guidelines for management of patients with chronic heart failure in Australia. Med J Aust. 2001;174:459–466
  3. Lowery SL, Massaro R, Yancy CW. Advances in the management of acute and chronic decompensated heart failure. Lippincotts Case Manag. 2004;9:S1–S15quiz S16–17
  4. Field B. Heart failure...what of the future?. Australian Institute of Health and Welfare AIHW. 2003;Bulletin no.6
  5. Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41:1529–1538
  6. American Heart Association . Heart disease and Stroke Statistics — 2005 Update. Dallas, Texas: American Heart Association; 2005;
  7. NHLBI:(National Heart, Lung and Blood Institute) . Congestive heart failure in the United States: A new epidemic. National Heart, Lung and Blood Institute; 1996;www.nhlbinih.gov/health/public/heart/other/CHF.htm
  8. Davies M, Hobbs F, Davis R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001;358:439–444
  9. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527–1560
  10. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  11. Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22:228–236
  12. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  13. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  14. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation. 1994;90:1765–1773
  15. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.. Lancet. 1999;353:9–13
  16. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. Jama. 2004;292:344–350
  17. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7–13
  18. Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002–1008
  19. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987–1996
  20. Fair JM. Cardiovascular risk factor modification: is it effective in older adults?. J Cardiovasc Nurs. 2003;18:161–168
  21. Bonow RO, Smaha LA, Smith SC, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 2002;106:1602–1605
  22. Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol. 2004;43:642–648
  23. Anker SD, Clark AL, Winkler R, et al. Statin use and survival in patients with chronic heart failure—results from two observational studies with 5200 patients. Int J Cardiol. 2006;112:234–242
  24. Krum H, Tonkin A. The rosuvastatin impact on ventricular remodeling cytokines and neurohormones (UNIVERSE) study. J Am Coll Cardiol. 2006;47:61A–62A
  25. Naccarelli GV, Wolbrette DL, Patel HM, Luck JC. Amiodarone: clinical trials. Curr Opin Cardiol. 2000;15:64–72
  26. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet. 2003;362:147–158
  27. Hampton JR. Different causes of heart failure need different treatment strategies. J Cardiovasc Pharmacol. 1999;33(Suppl 3):S37–S41

PII: S0167-5273(07)01262-4

doi: 10.1016/j.ijcard.2007.07.014

International Journal of Cardiology
Volume 129, Issue 2 , Pages 198-204 , 26 September 2008

Article Tools

* Image Usage & Resolution